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Abstract
Background: To compare the cognitive profile of older patients with schizophrenia to those with other neuropsychiatric
disorders assessed in a hospital-based memory clinic.
Methods: Demographic, clinical, and cognitive data of all patients referred to the memory clinic at the Centre for Addiction
and Mental Health between April 1, 2006 and August 15, 2008 were reviewed. We then identified four groups of older
patients with: (1) late-life schizophrenia (LLS) and no dementia or depression (DEP); (2) Alzheimer’s disease (AD); (3) DEP and
no dementia or LLS; (4) normal cognition (NC) and no DEP or LLS.
Results: The four groups did not differ in demographic data except that patients with AD were about 12 years older than
those with LLS. However, they differed on cognitive tests even after controlling for age. Patients with LLS were impaired on
most cognitive tests in comparison with patients with NC but not on recalling newly learned verbal information at a short
delay. They experienced equivalent performance on learning new verbal information in comparison with patients with AD,
but better performance on all other tests of memory, including the ability to recall newly learned verbal information. Finally,
they were more impaired than patients with DEP in overall memory.
Conclusions: Patients with LLS have a different cognitive profile than patients with AD or DEP. Particularly, memory
impairment in LLS seems to be more pronounced in learning than recall. These findings suggest that cognitive and
psychosocial interventions designed to compensate for learning deficits may be beneficial in LLS.
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Introduction
Cognitive deficits are common in patients with schizophrenia or
depression (DEP) including in late life [1], [2]. In patients with
schizophrenia, specific deficits, such as memory impairment, are
reliable predictors of function [3], and are considered critical
targets for the development of novel pharmacological or
psychosocial therapies [4]. Thus, the identification of the cognitive
deficits that are specific to late-life schizophrenia (LLS) in contrast
to late-life DEP or other neuropsychiatric disorders (e.g.,
Alzheimer’s disease (AD)) is critical to facilitate diagnosis and
support the development of specific treatment interventions
(‘‘personalized treatment’’). For example, an effective cognitive
intervention can be tailored to a specific cognitive function that is
more impaired in LLS than in DEP. A similar selective approach
could be applied to combinations of disorders (e.g., LLS and DEP
or LLS and AD). To our knowledge, only a few published studies
compared patients with LLS to those with AD [2,5,6,7,8], and
none to those with DEP. Furthermore, and except for Heaton et al
[2], these studies reported on a global cognitive test (e.g., Mini-
Mental State Examination or Dementia Rating Scale total score)
or a brief cognitive battery (e.g., 3 tests from the Consortium to
Establish a Registry for Alzheimer’s Disease) which limited their
ability to distinguish specific cognitive deficits in different cognitive
domains. Thus, we took advantage of the comprehensive cognitive
assessment that is administered to patients referred to hospital-
based memory clinic and we compared the cognitive profiles of
patients with LLS to those of patients with AD, DEP, or ‘‘normal
cognition’’ (NC).
Methods
Setting and Subjects
The Centre for Addiction and Mental Health (CAMH) in
Toronto, Canada is a unique and large academic specialty hospital
that provides psychiatric care (including care to patients with
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dementia) to an urban catchment area and serves as a referral
center for a large suburban and rural population. This analysis was
based on a review of the health records of all patients referred for a
consultation to the memory clinic at CAMH between April 1,
2006 and August 15, 2008. These patients had undergone a
comprehensive assessment including a neurological evaluation (by
D.F.T-W.), a psychiatric examination (by Z.I.), and cognitive
testing (by N.A.). Diagnoses were ascertained using a consensus
process that was mainly guided by the neurological and psychiatric
assessments. However, patients with schizophrenia had this
diagnosis established by the referring source and then confirmed
by the psychiatrist (Z.I.) at the memory clinic. Since this study was
based on the review of health records of patients who were already
assessed at the memory clinic, no informed consent from the
patients was obtained and the data were analyzed anonymously.
The Centre for Addiction and Mental Health Research Ethics
Board waived the need for consent and approved the study.
Data Abstraction
Charts were reviewed and data abstracted by two investigators
(C.T., and T.K.R.) using a standardized form. The following tests
were recorded and analyzed: age, sex, education, neuropsychiatric
diagnoses, residential type, and cognitive data. The cognitive
battery used at the memory clinic includes the following tests:
Animal Fluency [9], Boston Naming Test [10], Clock drawing test
– Freedman scale (Clock) [11], California Verbal Learning Test II-
Short Form (CVLT) [12], Dementia Rating Scale-2 (DRS) [13],
FAS Letter Fluency (FAS) [9], Luria Alternating Diagrams [14],
Mini-Mental Status Examination (MMSE) [15], Trail Making
Test A and B (TMA, TMB) [16], and Wisconsin Card Sorting
Test – 64 (WCST) [17]. Following McBride et al [7], we
calculated two CVLT Saving Scores: one for Short Delay Free
Recall and another for Long Delay Free Recall. We generated
these scores by dividing the number of correct responses at Short
Delay Free Recall (or Long Delay Free Recall) by the number of
correct responses at the last trial of acquisition of CVLT, and
multiplying the answer by 100.
Data Analysis
After completing the clinical and cognitive assessments, a
consultation report was generated for each referred patient. The
report included a neuropsychiatric diagnostic formulation that was
based on the application of the Diagnostic and Statistical Manual
of Mental Disorders, Fourth Edition, Text Revision criteria to the
data obtained during these assessments. We used this diagnostic
formulation to identify (1) a group of patients with LLS and
without a diagnosis of dementia; from the rest of the patients, we
created three comparison groups: (2) a group of patients with AD
and without another mental disorder; (3) a group of patients with
DEP and no dementia; and (4) a group of patients without a
neuropsychiatric disorder and with NC. The latter group (NC)
consisted of individuals who were referred to the clinic for memory
concerns or complaints and who were ascertained to be cognitively
intact based on their clinical and cognitive assessments. First,
we characterized descripitively the four groups of patients.
Then, we compared the demographic, clinical, and cognitive
characteristics of the four groups using one-way analyses of
variance (ANOVA). When differences were found, we used post-
hoc comparisons with Bonferroni’s corrections to correct for
multiple comparisons. Cohen’s effect sizes (d’s) were calculated for
differences between LLS and the other three groups on all
cognitive tests. Data analyses were conducted using SPSS 15.0 for
Windows.
Results
Diagnostic groups
One hundred twenty four individual patients were assessed at
the memory clinic during the study period. Five patients were
excluded due to language barriers preventing the completion of
significant portions of the comprehensive assessment. Of the
remaining 119 patients, 52 patients were excluded for the
following diagnoses: cognitive disorder not-otherwise specified:
N= 10; alcohol-related disorder: N= 5; schizophrenia and de-
mentia N= 5; bipolar disorder: N= 4; depression and dementia:
N= 4; frontal lobe degeneration/syndrome or semantic dementia:
N= 4; mental retardation: N=4; dementia with Lewy bodies:
N= 3; corticobasal degeneration syndrome: N= 2; dementia not-
otherwise specified: N= 2; dementia with multiple etiologies:
N= 2; mild cognitive impairment with parkinsonism: N= 2;;
Alzheimer’s disease with primary progressive aphasia: N= 1;
asymmetrical cortical degeneration: N= 1; depression and de-
mentia with Lewy bodies: N=1; depression and possible
neurodegenerative disorder: N= 1;. vascular dementia: N= 1.
The remaining 67 patients were classified among the groups of
interest as follows: (1) LLS without dementia: N= 25; (2) AD:
N=15; (3) DEP: N= 15; (4) NC: N=12.
Demographic and clinical characteristics
The subjects’ characteristics data are summarized in Table S1.
Patients with LLS were not different from the other groups with
respect to sex distribution, education, race, community living
status, or number of active medical problems. However, on
average, they were 12 years younger than those with AD.
Cognitive characteristics
The cognitive characteristics of the four groups are presented in
Table S1 and Figure 1. After Bonferroni’s correction, the patients
with LLS performed significantly better than those with AD on
DRS Memory, CLOCK, CVLT Short Delay Free Recall Saving
Score and Long Delay Free Recall Saving Score, and Luria
Alternating Diagrams; performed significantly worse than those
with DEP on DRS Memory, Animal Fluency, CVLT Short Delay
Free Recall, and Long Delay Free Recall, and WCST Categories;
and worse than those with NC on MMSE, DRS Total and
Memory, Animal Fluency, Boston Naming Test, CVLT 1-4, Short
Delay Free Recall, Long Delay Free Recall and Long Delay Free
Recall Saving Score, FAS, Luria Alternating Diagrams, TMA
Time, and WCST Categories.
We also performed the same analyses excluding subjects above
the age of 50 (2 subjects with LLS and 1 subject with NC). The
only significant change is that the difference between patients with
LLS and those with DEP on FAS became significant (p = 0.042).
Discussion
Using a comprehensive cognitive assessment, we compared the
cognitive profiles of patients seen at a hospital-based memory
clinic with LLS, AD, DEP, or NC. Three main findings emerge
from this analysis: (1) patients with LLS were impaired on most
cognitive tests in comparison with patients with normal cognition
(NC); (2) patients with LLS experienced impairment on learning
new verbal information that was equivalent to that experienced by
patients with AD, but a significantly smaller impairment in their
ability to retrieve this newly learned verbal information; (3)
patients with LLS were more impaired than patients with DEP on
all tests of memory except the ability to retrieve newly learned
verbal information.
Cognition in Schizophrenia
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These findings need to be considered in the context of the
strengths and the limitations of this study. First, because this
memory clinic is based in a large psychiatric hospital, more than
half of the patients had primary psychiatric diagnoses (e.g.,
alcohol-related disorder, LLS, Bipolar disorder, DEP) usually not
represented in a community-based memory clinic. Due to this
heterogeneity in diagnosis, some patients had to be excluded from
the analysis and the four groups that were included were small.
This reduced the power to detect statistically significant differences
on specific tests, especially those of executive function (e.g., DRS
Initiation/Perseveration subscales, and WCST). Still, large and
highly significant differences on most tests were detected between
patients with LLS and those without a psychiatric diagnosis who
were referred by their primary care physicians due to memory or
cognitive complaints and found to have normal cognition. Second,
the deficits identified in these patients with LLS who were referred
to the clinic because of ‘‘memory complaints’’ may not generalize to
the larger population of older persons with LLS. This applies in
particular to the differences in the domain of memory.
Nevertheless, such a bias towards memory impairment should
not have affected the differences observed between the four
studied groups since all the patients seen in the clinic were referred
because of ‘‘memory complaints.’’ Third, patients with AD were
about 12 years older than patients with LLS. Thus, age may have
contributed to the more severe memory impairment seen in
patients with AD. However, our findings in memory did not
change significantly when we limited our analysis to patients age
50 or above. Further, a lesser memory impairment in LLS
compared to AD has also been reported in age-matched patients
[5,7]. Also, such a confound would not explain the equivalent
impairments in learning new verbal information but smaller
impairment in LLS compared to AD in the ability to retrieve
newly learned information. Finally, more than 80% of our patients
with LLS were community-dwellers and the current literature on
such patients suggests cognitive stability rather than decline with
age [18].
Notwithstanding the above limitations, our findings confirm and
extend our current understanding of cognition in LLS. The
ranking of the groups in terms of overall memory impairment (AD
, LLS , DEP) and the large effect sizes observed when patients
with LLS were compared with those with DEP and AD has
significant therapeutic and functional implications: interventions
to enhance cognition in LLS should have a special focus on
memory. Furthermore, memory correlates significantly with
everyday function such as hygiene, safety, cooking, and commu-
nity utilization in the geriatric population [19]. This suggests that
interventions enhancing memory could have a significant
functional impact, but that the impact may be different in patients
with different neuropsychiatric disorders.
In contrast to comparable deficits in learning new verbal
information (CVLT 1-4), patients with LLS experienced signifi-
cantly smaller deficits than those with AD in retrieving the newly
learned information (CVLT Short and Long Delay Free Recall
Saving Scores). In fact, they experienced comparable performance
to those with NC in recalling newly learned verbal information at
a short delay. These findings in LLS are consistent with previous
reports among mid to late life patients with schizophrenia,
suggesting that the memory impairment associated with LLS is
secondary to poor registration or organization of new information
and not impaired retrieval of learned information as in AD
[2,20,21]. This is relevant to the understanding of the cognitive
pathology in LLS compared to AD, and to the design of cognitive
Figure 1. Comparison of Cognitive Performances of Patients with Alzheimer’s Disease, Depressive Disorder, or Normal Cognition
to those with Late-Life Schizophrenia. Cohen’s effect sizes have been calculated and plotted for the different cognitive tests comparing
performances of patients with AD, DEP, or NC to those with LLS (who constitute the reference group). Positive effect sizes indicate that patients with
AD, DEP, or NC perform numerically better than patients with LLS. Negative effect sizes indicate that the opposite. * indicates that the difference is
statistically significant (p,0.05) after correcting for multiple comparisons. ** indicates that the difference is statistically significant (p,0.01) after
correcting for multiple comparisons. *** indicates that the difference is statistically significant (p,0.001) after correcting for multiple comparisons.
AD: Alzheimer’s disease; Clock: Clock drawing test – Freedman scale; CVLT: California Verbal Learning Test II- Short Form; DEP: depressive disorder;
DRS: Dementia Rating Scale-2; FAS: FAS Letter Fluency; MMSE: LLS: late-life schizophrenia; Mini-Mental Status Examination; NC: normal cognition;
TMA and TMB: Trail Making Test A and B, respectively; WCST: Wisconsin Card Sorting Test – 64.
doi:10.1371/journal.pone.0010151.g001
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interventions. Facilitating the encoding of new information is likely
to have a more meaningful and clinically significant impact in LLS
than in AD (because the chance of retrieving encoded information
is higher in LLS than AD).
Other than memory, patients with LLS performed better than
patients with AD on the CLOCK, a test of visuospatial ability
(amongst other abilities). Thus, like recall, visuospatial ability
appears to be another cognitive function that can be used in
differentiating cognitively impaired patients with LLS from those
with AD. Furthermore, visuospatial ability has also been associated
with function and has been reported to decline in a longitudinal
study of subjects with LLS who were older than our patients
[22,23]. Thus, it can also be a target for interventions to enhance
their cognition.
Finally, as expected patients with LLS were impaired in
executive function compared to patients with DEP or NC on
one test (WCST Categories). However, no such impairment was
observed in other tests (e.g., TMB). Small sample sizes are likely
contributing to such inconsistency.
Conclusion
In conclusion, patients with LLS and no dementia can be
distinguished from patients with other neuropsychiatric disorders
by their distinct cognitive profile, in particular their relatively
intact recall of learned information and visuospatial ability. This
finding may be useful in the development of interventions to
enhance the cognition of patients with LLS.
Supporting Information
Table S1 LLS: late-life schizophrenia; AD: Alzheimer’s disease;
DEP: depressive disorder; NC: normal cognition. -- All results
presented as mean scores (SD) unless specified otherwise. *:
group(s) significantly different from LLS after Bonferroni’s
correction **: duration of illness available for 13 patients with
LLS, 1 patient with DEP, and no one with AD or NC [n] =
number of individuals contributing to the mean {n} = Cohen’s
effect size of the comparison between AD, DEP, or NC group with
LLS group.
Found at: doi:10.1371/journal.pone.0010151.s001 (0.09 MB
DOC)
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